Diabetes Channel
Topics
Medications
Quicklinks
Related Channels

Drug Information -- Darbepoetin Alfa

The U.S. Food and Drug Administration (FDA) has approved darbepoetin alfa (Aranesp®) for the treatment of anemia related to chemotherapy or chronic kidney failure. The medicine comes in injectable form and is given either subcutaneously or intravenously. It works by stimulating the production of red blood cells in the bone marrow.
 
Safety information on darbepoetin alfa should be reviewed with your healthcare provider prior to beginning treatment so that you are aware of all the risks. This includes possible side effects, such as diarrhea, muscle pain, and fatigue, and being aware of the drugs that can cause negative interactions.
 
(Click Darbepoetin Alfa for more information on this drug. Topics covered in this article include whether the medication is available in generic form, what to do if you are pregnant or breastfeeding, and more.)
 

Drug Information -- Darbepoetin Alfa

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.